Page 298 - Read Online

7. Akhondi H, Barochia S, Holmström B, Williams MJ. Hydrocephalus 12. Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM.
as a presenting manifestation of neurosarcoidosis. South Med J Cerebrospinal fluid angiotensin‑converting enzyme for
2003;96:403‑6. diagnosis of central nervous system sarcoidosis. Neurologist
8. Kim SH, Lee SW, Sung SK, Son DW. Treatment of hydrocephalus 2009;15:108‑11.
associated with neurosarcoidosis by multiple shunt placement. 13. Qian X, Goumnerova LC, De Girolami U, Cibas ES. Cerebrospinal
J Korean Neurosurg Soc 2012;52:270‑2. fluid cytology in patients with ependymoma: a bi‑institutional
9. Tabuchi S, Uno T. Hydrocephalus with panventricular enlargement retrospective study. Cancer 2008;114:307‑14.
as the primary manifestation of neurosarcoidosis: a case report. 14. Androdias G, Maillet D, Marignier R, Pinède L, Confavreux C,
J Med Case Rep 2013;7:240. Broussolle C, Vukusic S, Sève P. Mycophenolate mofetil may be
10. van Rooijen JM, Mijnhout GS, Aalders TT, de Bondt RB. effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology
Hydrocephalus, a rare manifestation of sarcoidosis. Clin Pract 2011;76:1168‑72.
2011;1:e66. 15. Moravan M, Segal BM. Treatment of CNS sarcoidosis with infliximab
11. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, and mycophenolate mofetil. Neurology 2009;72:337‑40.
Bitker MO, Bletry O, Laplane D, Bousser MG, Godeau P. 16. Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive
Neurosarcoidosis: signs, course and treatment in 35 confirmed therapy for neurosarcoidosis: long‑term follow‑up of 48 treated
cases. Medicine (Baltimore) 1990;69:261‑76. patients. Arch Neurol 2007;64:691‑6.

290 Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015 PB